<DOC>
	<DOCNO>NCT00335452</DOCNO>
	<brief_summary>The purpose study evaluate whether high dosage clopidogrel aspirin ( two dos ) decrease risk ischemic complication ( cardiac death ( CV death ) , myocardial infarction ( MI ) , stroke ) percutaneous coronary intervention ( PCI ) .</brief_summary>
	<brief_title>Clopidogrel Optimal Loading Dose Usage Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy InterventionS</brief_title>
	<detailed_description />
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Diagnosed acute coronary disease clinical symptom least electrocardiogram change cardiac enzymes elevate Use anticoagulant within 10 day international normalized ratio ( INR ) &gt; 1.5 plan use hospitalisation period Administration clopidogrel &gt; 75 mg prior randomization Contraindication clopidogrel aspirin Active bleed significant risk bleeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>platelet aggregation inhibitor</keyword>
	<keyword>acute coronary disease</keyword>
	<keyword>percutaneous coronary</keyword>
</DOC>